Fig. 1 · Structure
Documents & Downloads
DA 3003-2
Cdc25 Inhibitor
DA 3003-2 is a potent inhibitor of Cdc25, exhibiting selective inhibition of this critical cell cycle regulator. This compound demonstrates significant antiproliferative activity, effectively inducing cell cycle arrest in the G2/M phase and enhancing the expression of phosphorylated tyrosine 15 on Cdc2. DA 3003-2 holds promise for advancing research into prostate cancer therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 383907-47-9 |
| Applications | Cdc25 Inhibitor |
| Formula | C15H16ClN3O3 |
| Molecular Weight | 321.76 |
| Synonyms | NSC663285 |
| SMILES | O=C(C1=C(C2=O)N=CC=C1)C(NCCN3CCOCC3)=C2Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.